Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Publications

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Fetuin-A, inter-alpha-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes.

PMID: 35075803
Journal: Clinical and Translational Medicine
Year: 2022
Reference: Clin Transl Med. 2022 Jan;12(1):e704. doi: 10.1002/ctm2.704.
Impact factor:
Publication type: Letter whit IF
Authors: Auguet, Teresa; Benavent-Bofill, Clara; Boque, Carme; Burgos, Joaquin; Buzon, Maria Jose; Garcia-Pardo, Graciano; Gomez-Bertomeu, Frederic; Gutierrez-Valencia, Alicia; Lopez-Cortes, Luis F; Marti, Anna et al.
DOI: 10.1002/ctm2.704

Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study.

PMID: 35403189
Journal: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Year: 2022
Reference: J Antimicrob Chemother. 2022 Jun 29;77(7):1996-2002. doi: 10.1093/jac/dkac106.
Impact factor: 5.79
Publication type: Paper in international publication
Authors: Cobo Reinoso, Javier, Lopez Medrano, Francisco, De La Torre Cisneros, Julian, Gutierrez, Belen, Escudero-Sanchez, Rosa, Muriel Garcia, Alfonso, Garcia Fernandez, Sergio, Valencia Alijo, Angela, Tasias Pitarch, Mariona, Merino De Lucas, Esperanza et al.
DOI: 10.1093/jac/dkac106

Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study.

PMID: 35403189
Journal: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Year: 2022
Reference: J Antimicrob Chemother. 2022 Jun 29;77(7):1996-2002. doi: 10.1093/jac/dkac106.
Impact factor:
Publication type: Paper in international publication
Authors: Arminanzas Castillo, Carlos; Cano Yuste, Angela; Cobo Reinoso, Javier; De La Torre Cisneros, Julian; Diaz Pollan, Beatriz; Escudero-Sanchez, Rosa; Fernandez Fradejas, Jorge; Garcia Basas, Lorena; Garcia Fernandez, Sergio; Giner, Livia et al.
DOI: 10.1093/jac/dkac106

Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma.

PMID: 34940781
Journal: JAMA Oncology
Year: 2022
Reference: JAMA Oncol. 2022 Feb 1;8(2):275-280. doi: 10.1001/jamaoncol.2021.5981.
Impact factor: 31.777
Publication type: Paper in international publication
Authors: Motzer, Robert J, Powles, Thomas, Atkins, Michael B, Escudier, Bernard, McDermott, David F, Alekseev, Boris Y, Lee, Jae-Lyun, Suarez, Cristina, Stroyakovskiy, Daniil, De Giorgi, Ugo et al.
DOI: 10.1001/jamaoncol.2021.5981

Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma.

PMID: 34940781
Journal: JAMA Oncology
Year: 2022
Reference: JAMA Oncol. 2022 Feb 1;8(2):275-280. doi: 10.1001/jamaoncol.2021.5981.
Impact factor:
Publication type: Paper in international publication
Authors: Alekseev, Boris Y; Atkins, Michael B; Banchereau, Romain; Craine, Veronica; De Giorgi, Ugo; Donskov, Frede; Dubey, Sarita; Escudier, Bernard; Flinn, Nick; Hamidi, Habib et al.
DOI: 10.1001/jamaoncol.2021.5981

Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.

PMID: 35577646
Journal: EUROPEAN UROLOGY
Year: 2022
Reference: Eur Urol. 2022 Aug;82(2):212-222. doi: 10.1016/j.eururo.2022.04.013. Epub 2022 May 14.
Impact factor: 20.096
Publication type: Paper in international publication
Authors: Szabados, Bernadett, Kockx, Mark, Assaf, Zoe June, van Dam, Pieter-Jan, Rodriguez-Vida, Alejo, Duran, Ignacio, Crabb, Simon J, Van Der Heijden, Michiel S, Pous, Albert Font, Gravis, Gwenaelle et al.
DOI: 10.1016/j.eururo.2022.04.013

Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.

PMID: 35577646
Journal: EUROPEAN UROLOGY
Year: 2022
Reference: Eur Urol. 2022 Aug;82(2):212-222. doi: 10.1016/j.eururo.2022.04.013. Epub 2022 May 14.
Impact factor:
Publication type: Paper in international publication
Authors: Aleshin, Alexey; Assaf, Zoe June; Banchereau, Romain; Castellano, Daniel; Crabb, Simon J; Daelemans, Sofie; Duran, Ignacio; Gravis, Gwenaelle; Herranz, Urbano Anido; Kockx, Mark et al.
DOI: 10.1016/j.eururo.2022.04.013

Final Safety and Efficacy Results from a 106 Real-World Patients Registry with an Ascites-Mobilizing Pump.

PMID: 35686702
Journal: LIVER INTERNATIONAL
Year: 2022
Reference: Liver Int. 2022 Jun 10. doi: 10.1111/liv.15337.
Impact factor: 5.828
Publication type: Paper in international publication
Authors: Herber, Adam, Trepte, Claudia, Capel, Jeroen, De Gottardi, Andrea, Engelmann, Cornelius, Geier, Andreas, Vargas, Victor, Babatz, Jana, Stirnimann, Guido, Berg, Thomas et al.
DOI: 10.1111/liv.15337

Final Safety and Efficacy Results from a 106 Real-World Patients Registry with an Ascites-Mobilizing Pump.

PMID: 35686702
Journal: LIVER INTERNATIONAL
Year: 2022
Reference: Liver Int. 2022 Oct;42(10):2247-2259. doi: 10.1111/liv.15337. Epub 2022 Jul 25.
Impact factor:
Publication type: Paper in international publication
Authors: Babatz, Jana; Banz, Vanessa; Berg, Thomas; Capel, Jeroen; De Gottardi, Andrea; Engelmann, Cornelius; Geier, Andreas; Herber, Adam; Lammert, Frank; McPherson, Stuart et al.
DOI: 10.1111/liv.15337

Final safety and HRQoL results of the phase II/III Act.In.Sarc study with preoperative NBTXR3 plus radiotherapy versus radiotherapy in locally advanced soft-tissue sarcoma.

PMID: 35850363
Journal: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOG
Year: 2022
Reference: Int J Radiat Oncol Biol Phys. 2022 Jul 15. pii: S0360-3016(22)00720-9. doi: 10.1016/j.ijrobp.2022.07.001.
Impact factor: 7.038
Publication type: Paper in international publication
Authors: Herraez, Antonio Casado; Tiangco, Beatrice J; Li, Rubi K; Moreno, Victor; Rastrelli, Marco; Mervoyer, Augustin; Sunyach, Marie-Pierre; Agoston, Peter; Ducassou, Anne; Carrere, Sebastien et al.
DOI: 10.1016/j.ijrobp.2022.07.001

Final safety and HRQoL results of the phase II/III Act.In.Sarc study with preoperative NBTXR3 plus radiotherapy versus radiotherapy in locally advanced soft-tissue sarcoma.

PMID: 35850363
Journal: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Year: 2022
Reference: Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):422-432. doi: 10.1016/j.ijrobp.2022.07.001. Epub 2022 Jul 16.
Impact factor:
Publication type: Paper in international publication
Authors: Agoston, Peter; Anghel, Rodica M; Austen, Lyn; Bonvalot, Sylvie; Bovee, Judith V M G; Carrere, Sebastien; Cesne, Axel Le; de Baere, Thierry; Dimitriu, Mikaela; Ducassou, Anne et al.
DOI: 10.1016/j.ijrobp.2022.07.001

Fine Control of In Vivo Magnetic Hyperthermia Using Iron Oxide Nanoparticles with Different Coatings and Degree of Aggregation.

PMID: 35893782
Journal: Pharmaceutics
Year: 2022
Reference: Pharmaceutics. 2022 Jul 22;14(8). pii: pharmaceutics14081526. doi: 10.3390/pharmaceutics14081526.
Impact factor:
Publication type: Paper in international publication
Authors: Abasolo, Ibane; Artes-Ibanez, Emilio J; Diaz-Riascos, Zamira V; Garcia-Soriano, David; Ibarrola, Oihane; Luengo, Yurena; Miranda, Rodolfo; Salas, Gorka; Schwartz, Simo Jr; Somoza, Alvaro et al.
DOI: 10.3390/pharmaceutics14081526

First clinical multicenter experience with the new Pipeline Vantage flow diverter.

PMID: 35172983
Journal: Journal of NeuroInterventional Surgery
Year: 2022
Reference: J Neurointerv Surg. 2022 Feb 16. pii: neurintsurg-2021-018480. doi: 10.1136/neurintsurg-2021-018480.
Impact factor: 5.836
Publication type: Paper in international publication
Authors: Cekirge, H Saruhan, Vollherbst, Dominik F, Onal, Baran, Koc, Osman, Rautio, Riitta, Sinisalo, Matias, Tomasello, Alejandro, Vega, Pedro, Martinez-Galdamez, Mario, Lynch, Jeremy et al.
DOI: 10.1136/neurintsurg-2021-018480

First Description of Late-Onset Autoinflammatory Disease Due to Somatic NLRC4 Mosaicism.

PMID: 34672126
Journal: Arthritis & Rheumatology
Year: 2022
Reference: Arthritis Rheumatol. 2022 Apr;74(4):692-699. doi: 10.1002/art.41999. Epub 2022 Feb 14.
Impact factor: 10.995
Publication type: Paper in international publication
Authors: Ionescu, Daniela, Penin-Franch, Alejandro, Mensa-Vilaro, Anna, Castillo, Paola, Hurtado-Navarro, Laura, Molina-Lopez, Cristina, Romero-Chala, Silvia, Plaza, Susana, Fabregat, Virginia, Bujan, Segundo et al.
DOI: 10.1002/art.41999

First Description of Late-Onset Autoinflammatory Disease Due to Somatic NLRC4 Mosaicism.

PMID: 34672126
Journal: Arthritis & Rheumatology
Year: 2022
Reference: Arthritis Rheumatol. 2022 Apr;74(4):692-699. doi: 10.1002/art.41999. Epub 2022 Feb 14.
Impact factor:
Publication type: Paper in international publication
Authors: Arostegui, Juan I; Bujan, Segundo; Casals, Ferran; Castillo, Paola; Fabregat, Virginia; Fernandez-Pereira, Luis Miguel; Hurtado-Navarro, Laura; Ionescu, Daniela; Marques, Joana; Mensa-Vilaro, Anna et al.
DOI: 10.1002/art.41999

First documented outbreak of arthritis caused by Kingella kingae in a Spanish childcare center.

PMID: 35241399
Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Year: 2022
Reference: Enferm Infecc Microbiol Clin (Engl Ed). 2022 Apr;40(4):187-189. doi: 10.1016/j.eimce.2022.02.004. Epub 2022 Feb 28.
Impact factor: 1.731
Publication type: Paper in international publication
Authors: Villalobos, Pilar, Garcia-Gonzalez, Maria Del Mar, Guarch-Ibanez, Borja, Cabacas, Alicia, Gonzalez-Lopez, Juan Jose, Mora, Carme et al.
DOI: 10.1016/j.eimce.2022.02.004

First documented outbreak of arthritis caused by Kingella kingae in a Spanish childcare center.

PMID: 35241399
Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Year: 2022
Reference: Enferm Infecc Microbiol Clin. 2022 Apr;40(4):187-189. doi: 10.1016/j.eimce.2022.02.004. Epub 2022 Feb 28.
Impact factor:
Publication type: Paper in national publication
Authors: Cabacas, Alicia; Garcia-Gonzalez, Maria Del Mar; Gonzalez-Lopez, Juan Jose; Guarch-Ibanez, Borja; Mora, Carme; Villalobos, Pilar et al.
DOI: 10.1016/j.eimc.2020.11.006

First pass effect in posterior circulation occlusions: analysis from the cicat registry.

PMID: 35272563
Journal: International Journal of Stroke
Year: 2022
Reference: Int J Stroke. 2022 Apr 20:17474930221089772. doi: 10.1177/17474930221089772.
Impact factor: 5.266
Publication type: Paper in international publication
Authors: Terceno, Mikel, Chamorro, Angel, Perez de la Ossa, Natalia, Hernandez-Perez, Maria, Castano, C, Camps-Renom, Pol, Wenger, Denisse, Cardona, Pere, Molina, Carlos, Rodriguez-Campello, Ana et al.
DOI: 10.1177/17474930221089772

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers.

PMID: 35298698
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Year: 2022
Reference: Cancer Chemother Pharmacol. 2022 Apr;89(4):499-514. doi: 10.1007/s00280-022-04414-6. Epub 2022 Mar 17.
Impact factor: 3.333
Publication type: Paper in international publication
Authors: Felip, Enriqueta, Curigliano, Giuseppe, Rutkowski, Piotr, Trigo, Jose Manuel, Calvo, Aitana, Kowalski, Dariusz, Cortinovis, Diego, Plummer, Ruth, Maio, Michele, Ascierto, Paolo A et al.
DOI: 10.1007/s00280-022-04414-6

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers.

PMID: 35298698
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Year: 2022
Reference: Cancer Chemother Pharmacol. 2022 Apr;89(4):499-514. doi: 10.1007/s00280-022-04414-6. Epub 2022 Mar 17.
Impact factor:
Publication type: Paper in international publication
Authors: Ascierto, Paolo A; Attiyeh, Edward; Bandyopadhyay, Nibedita; Calvo, Aitana; Calvo, Emiliano; Cervantes, Andres; Cortinovis, Diego; Curigliano, Giuseppe; Felip, Enriqueta; Greger, James G et al.
DOI: 10.1007/s00280-022-04414-6

First-in-man histotripsy of hepatic tumors: the THERESA trial, a feasibility study.

PMID: 36002243
Journal: INTERNATIONAL JOURNAL OF HYPERTHERMIA
Year: 2022
Reference: Int J Hyperthermia. 2022;39(1):1115-1123. doi: 10.1080/02656736.2022.2112309.
Impact factor:
Publication type: Paper in international publication
Authors: Amaral, Joseph; Bolduan, Ryan; Cannata, Jon; Duryea, Alex; Hall, Timothy; Kam, Yossi; Lee, Fred T Jr; Merino, Xavier; Miller, Ryan; Serres, Xavier et al.
DOI: 10.1080/02656736.2022.2112309

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.

PMID: 35440667
Journal: BRITISH JOURNAL OF CANCER
Year: 2022
Reference: Br J Cancer. 2022 Jun;126(11):1548-1554. doi: 10.1038/s41416-022-01737-2. Epub 2022 Apr 19.
Impact factor: 7.64
Publication type: Paper in international publication
Authors: Van Cutsem, E, Danielewicz, I, Saunders, M P, Pfeiffer, P, Argiles, G, Borg, C, Glynne-Jones, R, Punt, C J A, Van de Wouw, A J, Fedyanin, M et al.
DOI: 10.1038/s41416-022-01737-2

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.

PMID: 35440667
Journal: BRITISH JOURNAL OF CANCER
Year: 2022
Reference: Br J Cancer. 2022 Jun;126(11):1548-1554. doi: 10.1038/s41416-022-01737-2. Epub 2022 Apr 19.
Impact factor:
Publication type: Paper in international publication
Authors: Amellal, N; Argiles, G; Borg, C; Danielewicz, I; Egorov, A; Falcone, A; Fedyanin, M; Fougeray, R; Garcia-Alfonso, P; Glynne-Jones, R et al.
DOI: 10.1038/s41416-022-01737-2

First-trimester screening for preeclampsia and small-for-gestational-age: A comparison of the Gaussian and FMF algorithms.

PMID: 35695395
Journal: INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
Year: 2022
Reference: Int J Gynaecol Obstet. 2022 Jun 13. doi: 10.1002/ijgo.14306.
Impact factor: 3.561
Publication type: Paper in international publication
Authors: Carreras, Elena, Mendoza, Manel, Armengol-Alsina, Mireia, Perestelo, Ana, Murcia, Maria Teresa, Serrano, Berta, Bonacina, Erika, Rodo, Carlota, Garcia-Manau, Pablo, Sanchez-Duran, Maria Angeles et al.
DOI: 10.1002/ijgo.14306